CHIEF EXECUTIVE OFFICER
Fri, Nov 15, 2024
Nov 15
4,750 shares @ $0.00
Decreased holdings by -11.10%
Net across this filing: +9.50% (+9,445 shares)
69th largest trade (out of 185)
Option ExercisePositive 90D History
Trade made by an officer
Sale tied to a same-time option exercise
Net holdings across this filing: +9.5% (+9,445 shares)
64% win rate · +2.3% median edge vs SPY (14 trades, 90-day · small sample)
Price 9% below 200-day moving average
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology